Hyperemesis Gravidarum News and Research RSS Feed - Hyperemesis Gravidarum News and Research

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013. [More]
Findings link antihistamine use to adverse pregnancy outcomes

Findings link antihistamine use to adverse pregnancy outcomes

Women with a severe form of morning sickness who take antihistamines to help them sleep through their debilitating nausea are significantly more likely to experience adverse pregnancy outcomes, including low birth weight babies and premature births, a UCLA study has found. [More]
Preemptive treatment effective for hyperemesis gravidarum and severe morning sickness

Preemptive treatment effective for hyperemesis gravidarum and severe morning sickness

`In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present data showing the effectiveness of preemptive treatment for hyperemesis gravidarum and severe morning sickness. [More]
Second trimester HG demands vigilance

Second trimester HG demands vigilance

Women who experience hyperemesis gravidarum during the second trimester have an increased risk for certain birth complications associated with placental abruption, study results show. [More]
Tzamal Medical, Duchesnay partner to distribute and sell Diclectin for management of NVP

Tzamal Medical, Duchesnay partner to distribute and sell Diclectin for management of NVP

Duchesnay Inc. and Tzamal Medical Group Ltd today announced that they have signed an agreement whereby Tzamal Medical Group has been granted exclusive rights to distribute and sell throughout the Israeli market the prescription medicine Diclectin (doxylamine 10 mg/pyridoxine 10 mg delayed-release tablet) indicated for the management of nausea and vomiting of pregnancy (NVP). [More]
Anti-seizure drug benefits women with severe morning sickness

Anti-seizure drug benefits women with severe morning sickness

Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a University at Buffalo professor who is conducting research on a drug that is showing success treating pregnant women with this condition. [More]
HER Foundation donates $46000 to UCLA geneticist for research into Hyperemesis Gravidarum

HER Foundation donates $46000 to UCLA geneticist for research into Hyperemesis Gravidarum

The HER Foundation proudly presented a check for more than $46 thousand to Dr. Marlena Fejzo, geneticist, of the David Geffen School of Medicine at UCLA on Friday, September 14th. [More]
Children of women with HG more likely to suffer from anxiety, bipolar disorder

Children of women with HG more likely to suffer from anxiety, bipolar disorder

An extreme form of pregnancy-related nausea and vomiting known as hyperemesis gravidarum (HG) takes a heavy toll on thousands of women each year and can lead to hospitalization and pregnancy termination. But new research suggests pregnant women are not the only victims. [More]
Extreme morning sickness drug comes at a price

Extreme morning sickness drug comes at a price

Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy. [More]
Family history of HG increases risk of extreme morning sickness during pregnancy

Family history of HG increases risk of extreme morning sickness during pregnancy

Approximately 60,000 pregnant women are hospitalized each year due to hyperemesis gravidarum (HG), an extreme form of nausea and vomiting that endangers their lives and often forces them to reluctantly terminate their pregnancies. [More]
Extreme nausea and vomiting varies among pregnant women from different countries

Extreme nausea and vomiting varies among pregnant women from different countries

Mothers born in India and Sri Lanka are three times more likely to suffer from extreme nausea and vomiting in pregnancy (hyperemesis gravidarum) than ethnic Norwegians. [More]
ACG offers updated clinical guidance for managing pregnant patients

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy. [More]
Morning sickness - a form of protection for mother and baby

Morning sickness - a form of protection for mother and baby

As many as 90% of mothers experience nausea during pregnancy, and about half that number vomit. [More]